Sharps Technology, Inc. (STSS) Short-Term Debt to Capital

Sharps Technology Inc - graphic logo of issuer STSS

This chart illustrates the current share price of Sharps Technology, Inc. (STSS) on the GURU.Markets platform, where the value stands at 0.00, based on clinics transitioning to secure injection methods and the efficiency of mass-producing disposable products. Stability of supplies to the hospital sector is maintained through developed pharmacy distribution channels, while management is currently configuring plants for commercial launch as they await confirmation of the first major deals.

STSS: Sharps Technology, Inc. Short-Term Debt to Capital Coefficient 04/28/2023 - 05/28/2026
Brand item of Sharps Technology, Inc.

This indicator assesses the proportion of short-term liabilities within the equity structure to determine the issuer's current solvency. By analyzing the ratio of short-term debt to the firm's equity, an investor can gauge the company's level of dependence on short-term loans. The current value of 0.00 reflects the balance between borrowed funds and core assets. For Sharps Technology, Inc. (STSS), this metric is critical, as intensive R&D for smart syringes requires stable funding without excessive debt pressure.

Analysis of competing companies

Intuitive Surgical Inc - Short-Term Debt to Capital|Current Liabilities to Capital Danaher Corporation Inc. (DHR)|BDX - Short-Term Debt to Capital|Short-Term Debt to Capital Ratio steris.com STE|Short-Term Debt to Capital WST (West Pharmaceutical Services, Inc.)|BAX - Short-Term Debt to Capital Coefficient|MASI (Masimo Personal Health) - Short-Term Debt to Capital|Stevanato Group Corp (STVN) - Short-Term Debt to Equity Ratio|TFX (Teleflex Incorporated) - Short-Term Debt to Capital|Short-Term Debt to Capital MMSI|Short-Term Debt to Equity Envista (NVST)|Short-Term Debt to Equity ICU Medical Inc ICUI|Short-Term Debt to Equity Ratio Dentsply|Ratio of Short-Term Indebtedness to Capital LeMaitre Corp LMAT|Short-Term Debt to Capital ATRC (AtriCure, Inc.)|STAA: Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Niagen|ZIMV (ZimVie Inc) - Short-Term Debt to Capital Ratio|ANGO: Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient Cerus Inc (CERS)|Short-Term Debt to Equity Ratio Alpha Teknova, Inc.|Short-Term Loans to Capital Ratio MGRM (monogramorthopedics.com)|Short-Term Debt to Equity InfuSystem Holdings, Inc.|UTMD - Ratio of Short-Term Indebtedness to Capital|KORU Medical Systems Inc. - Short-Term Debt to Equity Ratio|NYXH: Short-Term Debt to Capital|MBOT (Microbot Medical Inc.) - Short-Term Debt to Equity|pro-dex.com (PDEX) - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital ZTEK (Zentek)|Current Liabilities to Capital ELUT|Short-Term Debt to Equity Milestone Scientific Corp MLSS|Short-Term Debt to Capital Ratio NEXGEL Inc NXGL|Short-Term Debt to Equity Ratio Retractable Technologies, Inc. (RVP)|Harvard Bioscience Inc. - Short-Term Loans to Capital Ratio|Short-Term Debt to Equity FEMY (Femasys)|MHUA: Short-Term Debt to Capital Coefficient|predictive-oncology.com - Short-Term Debt to Equity|Callan JMB (CJMB) - Short-Term Debt to Capital Coefficient|ATRI - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital neurometrix.com